• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化还原电位和氧浓度作为幽门螺杆菌对硝基杂环药物敏感性的影响因素。

Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.

作者信息

Smith M A, Edwards D I

机构信息

Chemotherapy Research Unit, University of East London, UK.

出版信息

J Antimicrob Chemother. 1995 Jun;35(6):751-64. doi: 10.1093/jac/35.6.751.

DOI:10.1093/jac/35.6.751
PMID:7559187
Abstract

Metronidazole sensitive (MtzS) and resistant (MtzR) strains of Helicobacter pylori were tested for their sensitivities to eleven nitroheterocyclic drugs of known reduction potential under a wide range of environmental conditions. Under microaerophilic conditions, MtzR strains were sensitive to all the 2-nitroimidazoles, resistant to every 5-nitroimidazole, and slightly sensitive to the nitrothiazole, niridazole. MtzS strains were sensitive to all the nitroimidazoles except for 4(5)-nitroimidazole which has the lowest redox potential of all the drugs investigated. MtzS strains displayed the greatest sensitivity towards niridazole and satranidazole, the latter having the highest redox potential of the 5-nitroimidazoles. High and low oxygen tensions had no effect on the activity of the drugs but periods of anaerobic incubation caused resistant strains to become sensitive to the 5-nitroimidazoles. Superoxide dismutase and catalase were not induced by metronidazole and enzyme levels showed no correlation with resistance patterns. The results show that futile cycling does not occur in H. pylori and that the mechanism of action of the nitroimidazoles is related to their redox potential. Anaerobiosis abolishes resistance to metronidazole which suggests that it may be mediated through the activation of anaerobic metabolic pathways which function less under microaerophilic conditions or not at all.

摘要

在广泛的环境条件下,对甲硝唑敏感(MtzS)和耐药(MtzR)的幽门螺杆菌菌株进行了测试,以检测它们对11种已知还原电位的硝基杂环药物的敏感性。在微需氧条件下,MtzR菌株对所有2-硝基咪唑敏感,对每种5-硝基咪唑耐药,对硝基噻唑硝唑尼特稍有敏感。MtzS菌株对除4(5)-硝基咪唑外的所有硝基咪唑敏感,4(5)-硝基咪唑在所研究的所有药物中具有最低的氧化还原电位。MtzS菌株对硝唑尼特和塞曲硝唑表现出最大的敏感性,后者在5-硝基咪唑中具有最高的氧化还原电位。高氧和低氧张力对药物活性没有影响,但厌氧孵育期会使耐药菌株对5-硝基咪唑敏感。甲硝唑不会诱导超氧化物歧化酶和过氧化氢酶,酶水平与耐药模式无关。结果表明,幽门螺杆菌中不会发生无效循环,硝基咪唑的作用机制与其氧化还原电位有关。厌氧状态消除了对甲硝唑的耐药性,这表明它可能是通过激活厌氧代谢途径介导的,这些途径在微需氧条件下功能较弱或根本不发挥作用。

相似文献

1
Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.氧化还原电位和氧浓度作为幽门螺杆菌对硝基杂环药物敏感性的影响因素。
J Antimicrob Chemother. 1995 Jun;35(6):751-64. doi: 10.1093/jac/35.6.751.
2
Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori.幽门螺杆菌中的氧气清除、NADH氧化酶与甲硝唑耐药性
J Antimicrob Chemother. 1997 Mar;39(3):347-53. doi: 10.1093/jac/39.3.347.
3
The mode of action of metronidazole in Helicobacter pylori: futile cycling or reduction?甲硝唑对幽门螺杆菌的作用模式:无效循环还是还原作用?
J Antimicrob Chemother. 1998 Jan;41(1):67-75. doi: 10.1093/jac/41.1.67.
4
The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori.微需氧和厌氧对幽门螺杆菌摄取甲硝唑的影响。
J Antimicrob Chemother. 1995 Sep;36(3):453-61. doi: 10.1093/jac/36.3.453.
5
Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.幽门螺杆菌对甲硝唑耐药是由于一个编码对氧不敏感的NADPH硝基还原酶的基因(rdxA)发生无效突变所致。
Mol Microbiol. 1998 Apr;28(2):383-93. doi: 10.1046/j.1365-2958.1998.00806.x.
6
Mechanism and clinical significance of metronidazole resistance in Helicobacter pylori.幽门螺杆菌对甲硝唑耐药的机制及临床意义
Scand J Gastroenterol Suppl. 2001(234):10-4. doi: 10.1080/003655201753265055.
7
Proposed mechanism for metronidazole resistance in Helicobacter pylori.幽门螺杆菌对甲硝唑耐药的潜在机制。
J Antimicrob Chemother. 1992 Feb;29(2):115-20. doi: 10.1093/jac/29.2.115.
8
Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. The current situation.
J Physiol Pharmacol. 1997 Sep;48 Suppl 4:25-38.
9
A review on metronidazole: an old warhorse in antimicrobial chemotherapy.甲硝唑:抗菌化疗中的老战马述评
Parasitology. 2019 Aug;146(9):1167-1178. doi: 10.1017/S0031182017002025. Epub 2017 Nov 23.
10
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.抗生素敏感性在预测奥美拉唑、克拉霉素和替硝唑根除幽门螺杆菌失败中的相关性。
J Gastroenterol. 1998;33 Suppl 10:62-5.

引用本文的文献

1
Drug Repurposing in the Chemotherapy of Infectious Diseases.药物重定位在传染病化疗中的应用
Molecules. 2024 Jan 29;29(3):635. doi: 10.3390/molecules29030635.
2
Molecular Insight into Resistance to Nitrofuranyl Amides Gained through Metagenomics-like Analysis of Spontaneous Mutants.通过对自发突变体进行宏基因组学样分析获得的对硝基呋喃酰胺耐药性的分子洞察
Pharmaceuticals (Basel). 2022 Sep 12;15(9):1136. doi: 10.3390/ph15091136.
3
Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance.
溶组织内阿米巴的表型和转录谱分析揭示了与甲硝唑耐药性相关的适应性代价和适应性反应。
Front Microbiol. 2015 May 5;6:354. doi: 10.3389/fmicb.2015.00354. eCollection 2015.
4
Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis.具有体内抗非复制结核分枝杆菌疗效和活性的五环硝基呋喃类化合物。
PLoS One. 2014 Feb 5;9(2):e87909. doi: 10.1371/journal.pone.0087909. eCollection 2014.
5
Redox homeostasis in mycobacteria: the key to tuberculosis control?分枝杆菌中的氧化还原平衡:控制结核病的关键?
Expert Rev Mol Med. 2011 Dec 16;13:e39. doi: 10.1017/S1462399411002079.
6
Nitroimidazoles for the treatment of TB: past, present and future.硝基咪唑类药物治疗结核病:过去、现在和未来。
Future Med Chem. 2011 Sep;3(11):1427-54. doi: 10.4155/fmc.11.90.
7
Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.幽门螺杆菌抗生素耐药机制:最新评估
World J Gastrointest Pathophysiol. 2011 Jun 15;2(3):35-41. doi: 10.4291/wjgp.v2.i3.35.
8
Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori.幽门螺杆菌RdxA硝基还原酶的NAD(P)H氧化酶和甲硝唑还原酶活性的表征
FEBS J. 2009 Jun;276(12):3354-64. doi: 10.1111/j.1742-4658.2009.07060.x. Epub 2009 May 7.
9
A redox basis for metronidazole resistance in Helicobacter pylori.幽门螺杆菌甲硝唑耐药性的氧化还原基础
Antimicrob Agents Chemother. 2009 May;53(5):1884-91. doi: 10.1128/AAC.01449-08. Epub 2009 Feb 17.
10
Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.硝唑类药物在溶组织内阿米巴中的作用:硫氧还蛋白还原酶的核心作用
PLoS Biol. 2007 Aug;5(8):e211. doi: 10.1371/journal.pbio.0050211.